Record-Breaking Price Movement
The stock of Yatharth Hospital & Trauma Care Services Ltd surged to an intraday high of Rs 885.70, closing at Rs 888.00, just marginally above its 52-week high of Rs 887.15. This marks a new peak in the company’s market valuation, with the current price standing a mere 0.10% above the previous high. The day’s gain of 2.90% notably outpaced the Sensex’s 1.22% rise, underscoring the stock’s strong momentum in the hospital sector.
Over the past five trading sessions, the stock has recorded consecutive gains, delivering an impressive 8.85% return. This sustained rally has propelled the stock well above its key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, signalling a firm bullish trend.
Comparative Performance Against Benchmarks
Yatharth Hospital’s performance over various time frames has significantly outshone the broader market. The one-week return stands at 9.81%, compared to the Sensex’s 1.36%. Over one month, the stock surged 23.46%, while the Sensex declined by 0.43%. The three-month gain of 27.38% contrasts sharply with the Sensex’s 7.22% loss. Over the past year, the stock has appreciated by 70.44%, a remarkable feat against the Sensex’s 6.59% decline. Year-to-date, the stock has risen 30.29%, while the Sensex has fallen 10.42%.
These figures highlight the stock’s resilience and strong growth trajectory within the hospital sector, especially when benchmarked against the broader market indices.
Technical Analysis Confirms Bullish Momentum
The technical outlook for Yatharth Hospital remains firmly bullish. The overall trend shifted to bullish on 8 May 2026 at a price level of Rs 862.60, following a period of mild bullishness. Key technical indicators support this positive stance: the weekly MACD is bullish, Bollinger Bands indicate strength on both weekly and monthly charts, and the Dow Theory confirms bullishness across weekly and monthly timeframes.
Moving averages reinforce this trend, with the stock trading comfortably above all major averages. Immediate support is established at the 52-week low of Rs 484.90, while resistance levels at Rs 819.70 (20-day moving average), Rs 698.55 (100-day moving average), and Rs 723.89 (200-day moving average) have been decisively surpassed. The stock’s ability to breach these technical barriers has culminated in its new all-time high.
Valuation Metrics Reflect Premium Pricing
At the current price of Rs 888.00, Yatharth Hospital trades at a price-to-earnings (P/E) ratio of 50 times on a trailing twelve months (TTM) basis, indicating a premium valuation relative to earnings. The price-to-book value (P/BV) stands at 4.92 times, while enterprise value multiples such as EV/EBITDA and EV/EBIT are 30.98x and 42.53x respectively. The EV/Sales multiple is 7.40x, and EV/Capital Employed is 5.60x. The PEG ratio is calculated at 1.74x, suggesting valuation growth expectations are factored into the price.
Dividend metrics are not applicable as the company has not declared dividends recently, with no dividend yield or payout recorded.
Quality Assessment Highlights Financial Strength
Yatharth Hospital & Trauma Care Services Ltd is classified as an average quality company based on long-term financial performance. The management risk and growth profile are rated average, while the capital structure is excellent. The company maintains a negligible debt position, with an average debt to EBITDA ratio of 0.23 and a net cash position reflected by a negative net debt to equity ratio of -0.15.
Sales growth over five years has been robust at a compound annual growth rate (CAGR) of 30.84%, with EBIT growth at 15.55%. Interest coverage is strong, averaging 36.66 times, indicating ample capacity to service debt. The average return on capital employed (ROCE) is a healthy 19.03%, though return on equity (ROE) is relatively weak at 11.44%. Institutional holdings stand at a moderate 17.26%, and pledged shares constitute 10.73% of the total.
Recent Financial Trends Support Positive Outlook
Quarterly financial results demonstrate peak performance levels, with net sales reaching ₹320.47 crores, PBDIT at ₹74.25 crores, and PAT at ₹45.35 crores. Earnings per share (EPS) for the quarter stood at ₹4.71, marking the highest recorded values in recent periods. However, inventory turnover and debtors turnover ratios have declined to their lowest levels at 34.00 times and 2.92 times respectively, indicating areas for operational focus.
Delivery Volumes and Market Capitalisation
Delivery volumes have shown an upward trend, with a 1-month delivery change of 18.39% and a 1-day delivery change of 21.17% compared to the 5-day average. On 22 May 2026, delivery volume was recorded at 1.34 lakh shares, representing 48.22% of total volume, consistent with recent averages. The company is classified as a small-cap stock, reflecting its market capitalisation relative to the broader market.
Summary of Market and Stock Performance
Yatharth Hospital & Trauma Care Services Ltd’s stock has demonstrated exceptional strength, outperforming both its sector and the broader market indices across multiple time horizons. The stock’s recent all-time high price of Rs 888.00 is supported by solid financial results, a strong balance sheet, and positive technical indicators. The company’s premium valuation multiples reflect investor confidence in its earnings growth and market position within the hospital sector.
With a consistent upward trend and robust quarterly performance, Yatharth Hospital has established itself as a noteworthy performer in the healthcare space, marking this milestone as a testament to its sustained growth and financial discipline.
